Weatherly Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Sell
9,830
-33
-0.3% -$7.1K 0.18% 72
2026
Q1
$2.15M Buy
9,863
+2
+0% +$444 0.17% 75
2025
Q4
$2.25M Sell
9,861
-142
-1% -$32.3K 0.17% 74
2025
Q3
$2.32M Buy
10,003
+150
+2% +$30.5K 0.19% 77
2025
Q2
$1.83M Sell
9,853
-3
-0% -$558 0.16% 81
2025
Q1
$2.07M Sell
9,856
-62
-0.6% -$12.1K 0.19% 73
2024
Q4
$1.76M Sell
9,918
-92
-0.9% -$16.9K 0.16% 82
2024
Q3
$1.98M Buy
10,010
+1,152
+13% +$215K 0.17% 78
2024
Q2
$1.52M Sell
8,858
-567
-6% -$93.9K 0.14% 84
2024
Q1
$1.72M Hold
9,425
0.17% 84
2023
Q4
$1.46M Sell
9,425
-93
-1% -$13.6K 0.16% 87
2023
Q3
$1.42M Hold
9,518
0.17% 87
2023
Q2
$1.28M Buy
9,518
+264
+3% +$38.7K 0.15% 96
2023
Q1
$1.47M Hold
9,254
0.19% 89
2022
Q4
$1.5M Buy
9,254
+10
+0.1% +$1.53K 0.2% 84
2022
Q3
$1.24M Sell
9,244
-77
-0.8% -$11K 0.18% 88
2022
Q2
$1.43M Sell
9,321
-200
-2% -$30.6K 0.2% 87
2022
Q1
$1.54M Buy
9,521
+84
+0.9% +$12.2K 0.18% 94
2021
Q4
$1.28M Hold
9,437
0.14% 108
2021
Q3
$1.02M Hold
9,437
0.12% 111
2021
Q2
$1.06M Sell
9,437
-15
-0.2% -$1.69K 0.13% 108
2021
Q1
$1.02M Hold
9,452
0.14% 108
2020
Q4
$1.01M Hold
9,452
0.15% 107
2020
Q3
$828K Sell
9,452
-25
-0.3% -$2.35K 0.13% 107
2020
Q2
$930K Buy
9,477
+1,420
+18% +$125K 0.16% 96
2020
Q1
$614K Sell
8,057
-13
-0.2% -$1.11K 0.13% 107
2019
Q4
$715K Sell
8,070
-77
-0.9% -$6.39K 0.14% 112
2019
Q3
$617K Sell
8,147
-170
-2% -$11.7K 0.13% 118
2019
Q2
$605K Buy
8,317
+151
+2% +$11.9K 0.12% 121
2019
Q1
$658K Sell
8,166
-486
-6% -$39.8K 0.13% 118
2018
Q4
$798K Sell
8,652
-155
-2% -$13.6K 0.19% 102
2018
Q3
$833K Sell
8,807
-350
-4% -$33.2K 0.17% 107
2018
Q2
$848K Hold
9,157
0.2% 96
2018
Q1
$867K Sell
9,157
-2,317
-20% -$255K 0.21% 98
2017
Q4
$1.11M Sell
11,474
-52
-0.5% -$4.9K 0.27% 83
2017
Q3
$1.02M Sell
11,526
-161
-1% -$12.3K 0.27% 84
2017
Q2
$847K Buy
11,687
+150
+1% +$10.1K 0.24% 88
2017
Q1
$752K Buy
11,537
+31
+0.3% +$1.95K 0.22% 94
2016
Q4
$721K Hold
11,506
0.23% 91
2016
Q3
$726K Buy
11,506
+3,500
+44% +$227K 0.24% 91
2016
Q2
$496K Sell
8,006
-32
-0.4% -$1.95K 0.16% 117
2016
Q1
$459K Hold
8,038
0.16% 119
2015
Q4
$476K Sell
8,038
-205
-2% -$11.8K 0.17% 112
2015
Q3
$448K Hold
8,243
0.18% 105
2015
Q2
$553K Sell
8,243
-2,002
-20% -$131K 0.21% 94
2015
Q1
$599K Buy
10,245
+76
+0.7% +$4.59K 0.24% 94
2014
Q4
$665K Buy
10,169
+139
+1% +$8.76K 0.28% 85
2014
Q3
$579K Hold
10,030
0.25% 93
2014
Q2
$566K Sell
10,030
-380
-4% -$19.9K 0.24% 94
2014
Q1
$535K Sell
10,410
-70
-0.7% -$3.54K 0.25% 94
2013
Q4
$553K Sell
10,480
-1,347
-11% -$66.2K 0.26% 86
2013
Q3
$529K Sell
11,827
-625
-5% -$27.7K 0.27% 84
2013
Q2
$515K Buy
+12,452
New +$545K 0.28% 77

Other funds holding ABBV

Weatherly Asset Management's ABBV Position: Q2 2026 in Review

Weatherly Asset Management reduced its AbbVie (ABBV) stake by 0.33% in Q2 2026, selling an estimated $7.1K and leaving 9,830 shares worth $2.47M. The position accounts for 0.18% of the portfolio, ranked #72.

Weatherly Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Weatherly Asset Management held 9,830 shares of AbbVie worth $2.47M as of Q2 2026.
  • Weatherly Asset Management sold 33 AbbVie shares in Q2 2026, an estimated $7.1K.
  • AbbVie made up 0.18% of Weatherly Asset Management's portfolio in Q2 2026, its #72 holding.
  • Weatherly Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Weatherly Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.